Impact of Medicaid expansion and methadone coverage as a medication for opioid use disorder on foster care entries during the opioid crisis
| Autor: | Katie A. Ports, Andrea E. Strahan, Christopher R. Harper, Jennifer L. Matjasko, Curtis S. Florence, Shichao Tang, Whitney L. Rostad |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Child abuse
medicine.medical_specialty Sociology and Political Science business.industry media_common.quotation_subject Opioid use disorder medicine.disease Article Education Neglect Foster care Opioid Developmental and Educational Psychology Medicine Risk factor business Psychiatry Medicaid media_common Methadone medicine.drug |
| Zdroj: | Child Youth Serv Rev |
| Popis: | Between 2012 and 2018, incidents of opioid-involved injuries surged and the number of children in foster care due to parental drug use disorder increased. Treatments for opioid use disorder (OUD) might prevent or reduce the amount of time that children spend in the child welfare system. Using administrative data, we examined the impact of Medicaid expansion and state support for methadone as a medication for opioid use disorder (MOUD) on first-time foster care placements. Results show that first-time foster care entries due to parental drug use disorder experienced a reduction of 28 per 100,000 children in Medicaid expansion states with methadone MOUD covered by their state Medicaid programs. The largest reduction was found among non-Hispanic Black children and the youngest children (age 0–1 years). Policies that increase OUD treatment access may reduce foster care placements by reducing parents’ drug use, a risk factor for child abuse/neglect and subsequent home removal. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|